Agoraphobia Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Agoraphobia Market covers analysis By Treatment ( Medication, Therapy ); End User ( Hospitals, Specialty Clinics, Others ), and geography, and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00018625
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET INTRODUCTION



Agoraphobia is a disease of anxiety. In circumstances where escape may be difficult or hard to reach, it can cause extreme fear. Situations that may trigger fear in people with agoraphobia include crowded or enclosed spaces, open and remote spaces, and being far from home. Panic attacks or panic disorders are also present in certain people with agoraphobia. They can prevent a person from leaving their home when the symptoms are severe. Agoraphobia can develop at any age, but the symptoms typically occur between the ages of 25-35 and affect women more frequently than men.
MARKET DYNAMIC
Factors driving the growth of the agoraphobia market are the growing prevalence of genetic predisposition, sedentary lifestyles, stress, deteriorating health standards in the contemporary lifestyles, coupled with lack of intimacy in relations. However, the social stigma regarding psychotherapy, low focus and penetration of mental health in society, tendency to hide mental disorders and reluctance to therapy and treatment is expected to hamper the growth of the market. Moreover, increasing substance abuse and rising awareness and screening is anticipated to boost the market growth.

MARKET SCOPE



The "Agoraphobia Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of agoraphobia market with detailed market segmentation by treatment and end user. The agoraphobia market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in agoraphobia market and offers key trends and opportunities in the market.

MARKET SEGMENTATION



The agoraphobia market is segmented on the basis of treatment and end user. Based on treatment, the market is sub segmented as medication and therapy. The market by medication is segmented as antidepressants, anti-anxiety medications, and others. The market by therapy psychotherapy, cognitive behavioral therapy (CBT), and others. On the basis of end-user, the market is categorized as hospitals, specialty clinics, and others.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the agoraphobia market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The agoraphobia market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting agoraphobia market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the agoraphobia market in these regions.

MARKET PLAYERS



The report covers key developments in the agoraphobia market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from agoraphobia market are anticipated to have lucrative growth opportunities in the future with the rising demand for agoraphobia in the global market. Below mentioned is the list of few companies engaged in the agoraphobia market.

The report also includes the profiles of key players in agoraphobia market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  AstraZeneca
  •  Pfizer inc.
  •  GlaxoSmithKline plc
  •  Johnson & Johnson
  •  Sandoz Inc.
  •  Apotex Corp.
  •  Mylan Pharmaceuticals Inc.
  •  Eli Lilly & Co.
  •  Bristol-Myers Squibb
  •  Others

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Agoraphobia Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Treatment
  • Medication
  • Therapy
By End User
  • Hospitals
  • Specialty Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AstraZeneca
  • Pfizer inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Sandoz Inc.
  • Apotex Corp.
  • Mylan Pharmaceuticals Inc.
  • Eli Lilly & Co.
  • Bristol-Myers Squibb
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    1. AstraZeneca
    2. Pfizer inc.
    3. GlaxoSmithKline plc
    4. Johnson & Johnson
    5. Sandoz Inc.
    6. Apotex Corp.
    7. Mylan Pharmaceuticals Inc.
    8. Eli Lilly & Co.
    9. Bristol-Myers Squibb

    Buy Now